Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Shuangfeng, Xie"'
Autor:
Hongyun Liu, Xiaoyan Liu, Guoyang Zhang, Jieyu Wang, Duolan Naren, Shuangfeng Xie, Yiqing Li, Danian Nie, Zhixiong Li, Liping Ma
Publikováno v:
Thrombosis Research. 218:157-168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::621f9f5dbc65b9d643bb636a509229b6
https://doi.org/10.1016/j.thromres.2022.08.014
https://doi.org/10.1016/j.thromres.2022.08.014
Autor:
Yiqing, Li, Meng, Qiu, Boqi, Li, Jie, Xiao, Wenjuan, Yang, Shuangfeng, Xie, Yumo, Du, Kezhi, Huang, Danian, Nie
Publikováno v:
Translational Cancer Research. 11:2175-2184
T-cell lymphoma (TCL) has a very poor prognosis with limited treatment options and novel therapeutic target is urgently needed. Our previous studies have found that suppression of membrane-bound prostaglandin E2 synthase l/prostaglandin E2 (mPGES-1/P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9340ba4c3a9928d03906212c8adf3911
https://doi.org/10.21037/tcr-21-2834
https://doi.org/10.21037/tcr-21-2834
Autor:
Wenjuan Yang, Shuangfeng Xie, Yiqing Li, Jieyu Wang, Jie Xiao, Kezhi Huang, Xiuju Wang, Yudan Wu, Liping Ma, Danian Nie
Publikováno v:
Open Medicine. 17:1466-1472
Lymphoma relapse is very common in clinical work, but lineage switch at relapse is rare. Although some cases have reported acute lymphocytic leukemia (ALL) switch to acute myeloid leukemia (AML) or myeloid sarcoma upon relapse, phenotype switch seldo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01c8cb50c65b6c294891f635d31d83c5
https://doi.org/10.1515/med-2022-0521
https://doi.org/10.1515/med-2022-0521
Autor:
Zhao Yin, Meiyan Liao, Rongrong Yan, Guangchao Li, Ruiming Ou, Zhi Liu, Qi Zhong, Huijuan Shen, Yangmin Zhu, Shuangfeng Xie, Qing Zhang, Shuang Liu, Jing Huang
Publikováno v:
Functional & Integrative Genomics. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2231b592d2422ce5d0336ac31674fc8
https://doi.org/10.1007/s10142-023-00980-x
https://doi.org/10.1007/s10142-023-00980-x
Autor:
Zhao Yin, Meiyan Liao, Rongrong Yan, Guangchao Li, Ruiming Ou, Zhi Liu, Qi Zhong, Huijuan Shen, Yangmin Zhu, Shuangfeng Xie, Qing Zhang, Shuang Liu, Jing Huang
Olverembatinib represents the third-generation breakpoint cluster region protein-Abelson-murine leukemia 1 (BCR-ABL1) tyrosine kinase inhibitor (TKI) with oral bioavailability, which can be used to overcome the T315I mutation in Philadelphia chromoso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3552bc4e8c3e8ac95b9b161524bc2497
https://doi.org/10.21203/rs.3.rs-2402198/v1
https://doi.org/10.21203/rs.3.rs-2402198/v1
Autor:
Jie Xiao, Ben Zhang, Songmei Yin, Shuangfeng Xie, Kezhi Huang, Jieyu Wang, Wenjuan Yang, Hongyun Liu, Guoyang Zhang, Xiaoyan Liu, Yiqing Li, Danian Nie
Publikováno v:
Acta biochimica et biophysica Sinica.
Acute myeloid leukemia (AML) is one of the most common malignancies of the hematopoietic progenitor cell in adults. Quercetin has gained recognition over the years because of its anti-cancer effect with minimal toxicity. Herein, we aim to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f38fae41632c289f0e89a0be11d7ad
https://pubmed.ncbi.nlm.nih.gov/36148953
https://pubmed.ncbi.nlm.nih.gov/36148953
Autor:
Haiyan Zhang, Zhiping Fan, Fen Huang, Lijie Han, Yajing Xu, Na Xu, Lan Deng, Shunqing Wang, Dongjun Lin, Xiaodan Luo, Qing Zhang, Xiaodan Liu, Xudong Li, Xinquan Liang, Shuangfeng Xie, Hong Qu, Sijian Yu, Hongsheng Zhou, Pengcheng Shi, Li Xuan, Ren Lin, Hui Liu, Hua Jin, Jing Sun, Qifa Liu
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(2)
PURPOSE It remains controversial whether busulfan-based versus total body irradiation (TBI)–based regimens have comparable outcomes in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem-cell transplantation (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa57ba32cf33424e2291d8127e362e98
https://pubmed.ncbi.nlm.nih.gov/36084276
https://pubmed.ncbi.nlm.nih.gov/36084276
Publikováno v:
Pediatric bloodcancer. 70(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5687e29b8ea2316b4bcf984f3751ba0b
https://pubmed.ncbi.nlm.nih.gov/36069620
https://pubmed.ncbi.nlm.nih.gov/36069620
Publikováno v:
Open Medicine
Open Medicine, Vol 16, Iss 1, Pp 610-617 (2021)
Open Medicine, Vol 16, Iss 1, Pp 610-617 (2021)
Nocardiosis is a rare, life-threatening, opportunistic, and suppurative infection. Its clinical manifestation lacks specificity, which makes early diagnosis difficult. A retrospective analysis of the clinical records of 11 patients with nocardiosis a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1465b3e043eda547e41fb065dbccf93c
http://europepmc.org/articles/PMC8034244
http://europepmc.org/articles/PMC8034244
Autor:
Miao Miao, Depei WU, Shuangfeng Xie, Mei Hong, ChunKang Chang, Li Yu, Sujun Gao, Yan Li, Yuhua Li, Zunmin Zhu, Baolin Tang, Bingzong Li, Haiping Yang, Jishi Wang, Ling Qin, Rong Fu, Fei Li, Liangming Ma, Qifa Liu, Xin Du, Zhongxing Jiang, Zhenyu Li, Aijun Liu, Hongyan Tong, Jun Ma, Li Liu, Qingchi Liu, Yajing Xu, Hui Zhou, Yan Wang, Jianlin Chen, Ziru Niu, Mingxia Chen, Zhijian Xiao
Publikováno v:
Blood. 140:4045-4046
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e46568969f846ee98b76daeacb7abd0
https://doi.org/10.1182/blood-2022-155901
https://doi.org/10.1182/blood-2022-155901